CapitalBio Technology

  • CapitalBio Technology nets over RMB800m in new financing

    CapitalBio Technology has recently announced the completion of a new round of equity financing, and the actual amount raised exceeded the planned target of 800 million yuan.
    Guangdong Boye Architectural Design Institute led the round, with participation from Sinopec Capital, Meinian Onehealth Healthcare, New Alliance Capital, RedHorse Capital, Jiaxing Qiao Equity Investment Partnership